Cart
sales@molnova.com
TNF/IFNγ-IN-1
CAS No. 876013-29-5
TNF/IFNγ-IN-1( —— )
Catalog No. M37330 CAS No. 876013-29-5
TNF/IFNγ-IN-1 (TGA) is a dual inhibitor of TNF and IFN-γ. TNF/IFNγ-IN-1 has potential antioxidant and anti-inflammatory activities for neurodegenerative diseases such as Alzheimer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 259 | In Stock |
|
| 10MG | 360 | In Stock |
|
| 25MG | 596 | In Stock |
|
| 50MG | 775 | In Stock |
|
| 100MG | 1051 | In Stock |
|
| 200MG | 1423 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTNF/IFNγ-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionTNF/IFNγ-IN-1 (TGA) is a dual inhibitor of TNF and IFN-γ. TNF/IFNγ-IN-1 has potential antioxidant and anti-inflammatory activities for neurodegenerative diseases such as Alzheimer.
-
DescriptionTNF/IFN-γ-IN-1 (compound TGA) is a dual inhibitor of TNF and IFN-γ. TNF/IFN-γ-IN-1 can used in study Alzheimer’s disease.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX | Antioxidant | TNF
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number876013-29-5
-
Formula Weight401.41
-
Molecular FormulaC20H23N3O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN1=NN(C=C1C=2C=C(OC)C(OC)=C(OC)C2)C3=CC(OC)=C(OC)C(OC)=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Andrade VHB, et al. Neuroprotective Profile of Triazole Grandisin Analogue against Amyloid-Beta Oligomer-Induced Cognitive Impairment. ACS Chem Neurosci. 2023 Dec 20;14(24):4298-4310.?
molnova catalog
related products
-
4-Methylamino antipy...
4-Methylamino antipyrine is an active metabolite of Metamizole. Metamizole is a pyrazolone non-steroidal anti-inflammatory drug (NSAID) and inhibits COX.
-
Tolfenamic Acid
Tolfenamic acid (TA) is one of the class of non-steroidal anti-inflammatory drugs (NSAIDs).
-
Etoricoxib
Etoricoxib(MK-0663) selectively inhibited COX-2 in human whole blood assays in vitro, with an IC50 value of 1.1 ± 0.1 μM for COX-2 (LPS-induced prostaglandin E2 synthesis), compared with an IC50 value of 116 ± 8 μM for COX-1 (serum thromboxane B2 generation after clotting of the blood).
